Walt Linscott's most recent trade in Indaptus Therapeutics Inc was a trade of 54,421 Common Stock done at an average price of $2.0 . Disclosure was reported to the exchange on Dec. 22, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Indaptus Therapeutics Inc | Walt A. Linscott | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 2.03 per share. | 22 Dec 2025 | 54,421 | 54,426 | - | 2.0 | 110,475 | Common Stock |
| Indaptus Therapeutics Inc | Walt A. Linscott | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 10 Apr 2025 | 2,500 | 0 | - | - | Stock Option (right to buy) | |
| Indaptus Therapeutics Inc | Walt A. Linscott | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 10 Apr 2025 | 1,750 | 0 | - | - | Stock Option (right to buy) | |
| Indaptus Therapeutics Inc | Walt A. Linscott | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 10 Apr 2025 | 1,250 | 0 | - | - | Stock Option (right to buy) | |
| Indaptus Therapeutics Inc | Walt A. Linscott | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 10 Apr 2025 | 1,125 | 0 | - | - | Stock Option (right to buy) | |
| Indaptus Therapeutics Inc | Walt A. Linscott | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 10 Apr 2025 | 1,125 | 0 | - | - | Stock Option (right to buy) | |
| Indaptus Therapeutics Inc | Walt A. Linscott | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 10 Apr 2025 | 750 | 0 | - | - | Stock Option (right to buy) | |
| Indaptus Therapeutics Inc | Walt A. Linscott | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Oct 2024 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Indaptus Therapeutics Inc | Walt A. Linscott | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2024 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Indaptus Therapeutics Inc | Walt A. Linscott | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2023 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Indaptus Therapeutics Inc | Walt A. Linscott | Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 2.62 per share. | 07 Sep 2022 | 150 | 150 | - | 2.6 | 393 | Common stock |
| Indaptus Therapeutics Inc | Walt A. Linscott | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2022 | 45,850 | 45,850 | - | - | Stock Option (right to buy) | |
| Indaptus Therapeutics Inc | Walt A. Linscott | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2021 | 210,000 | 210,000 | - | - | Stock Option (right to buy) |